Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases
Por um escritor misterioso
Last updated 05 julho 2024
Niemann-Pick disease type C (NP-C) is a rare, autosomal recessive, neurodegenerative disease associated with a wide variety of progressive neurological manifestations. Miglustat is indicated for the treatment of progressive neurological manifestations in both adults and children. Since approval in 2009 there has been a vast growth in clinical experience with miglustat. The effectiveness of miglustat has been assessed using a range of measures. Comprehensive review of published data from studies of cellular neuropathological markers and structural neurological indices in the brain, clinical impairment/disability, specific clinical neurological manifestations, and patient survival. Cranial diffusion tensor imaging and magnetic resonance spectroscopy studies have shown reduced levels of choline (a neurodegeneration marker), and choline/N-acetyl aspartate ratio (indicating increased neuronal viability) in the brain during up to 5 years of miglustat therapy, as well as a slowing of reductions in fractional anisotropy (an axonal/myelin integrity marker). A 2-year immunoassay study showed significant reductions in CSF-calbindin during treatment, indicating reduced cerebellar Purkinje cell loss. Magnetic resonance imaging studies have demonstrated a protective effect of miglustat on cerebellar and subcortical structure that correlated with clinical symptom severity. Numerous cohort studies assessing core neurological manifestations (impaired ambulation, manipulation, speech, swallowing, other) using NP-C disability scales indicate neurological stabilization over 2–8 years, with a trend for greater benefits in patients with older (non-infantile) age at neurological onset. A randomized controlled trial and several cohort studies have reported improvements or stabilization of saccadic eye movements during 1–5 years of therapy. Swallowing was also shown to improve/remain stable during the randomized trial (up to 2 years), as well as in long-term observational cohorts (up to 6 years). A meta-analysis of dysphagia – a potent risk factor for aspiration pneumonia and premature death in NP-C – demonstrated a survival benefit with miglustat due to improved/stabilized swallowing function. The effects of miglustat on neurological NP-C manifestations has been assessed using a range of approaches, with benefits ranging from cellular changes in the brain through to visible clinical improvements and improved survival.
Disease characteristics, prognosis and miglustat treatment effects
Frontiers Adult-Onset Niemann–Pick Disease Type C: Rapid
Estimated prevalence of Niemann–Pick type C disease in Quebec
PDF) Effects of miglustat therapy on neurological disorder and
Neurodegeneration in NPC Disease
Frontiers Adult-Onset Niemann–Pick Disease Type C: Rapid
IJMS, Free Full-Text
Treatment outcomes following continuous miglustat therapy in
Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance
Recomendado para você
-
Niemann-Pick tipo C - Blog Mendelics05 julho 2024
-
Niemann Pick Disease Type C - Symptoms, Causes, Treatment05 julho 2024
-
IJMS, Free Full-Text05 julho 2024
-
NNPDF on X: October is Global Niemann-Pick Disease Awareness Month! For more information on Niemann-Pick Disease or to make a donation to NNPDF go to #niemannpick #ASMD #NPC #raredisease #NNPDF #NiemannPickC05 julho 2024
-
IJMS, Free Full-Text05 julho 2024
-
Parents of twins with Niemann-Pick find a treatment05 julho 2024
-
Niemann–Pick disease - Wikipedia05 julho 2024
-
Niemann Pick Disease - an overview05 julho 2024
-
SciELO - Brasil - Niemann-Pick disease type C: a case series of Brazilian patients Niemann-Pick disease type C: a case series of Brazilian patients05 julho 2024
-
Demência na infância: 'Meus três filhos receberam diagnóstico terminal' - BBC News Brasil05 julho 2024
você pode gostar
-
Comprar Boneca Reborn de Silicone com Acessorios Magazine Luiza05 julho 2024
-
Uma bola de futebol preta e amarela05 julho 2024
-
Warrior Season 4: If It's Happening, Possible Story, Cast05 julho 2024
-
Got Bears? Defenders of Wildlife05 julho 2024
-
Undefeated world champion boxer Beterbiev embraces life in Montreal05 julho 2024
-
Pokémon Memes - Poor Ditto05 julho 2024
-
FNAF SB Quiz05 julho 2024
-
Fidelity Bank Reinforces Commitment to Digital Technology, Adopts Open Banking - News Band05 julho 2024
-
Miraculous Cat Noir Glow in the Dark Ring05 julho 2024
-
Jack Produtos de Limpeza e Higiene, Videira SC05 julho 2024